Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00437190 · ClinicalTrials.gov registry record · NA

Pivotal IDE Study of the BRYAN(R) Cervical Disc Prosthesis in the Treatment of DDD Versus ACDF

A NA study, sponsored by Medtronic Spinal and Biologics.

Completed
Registry status
NA
Development phase
494
Enrollment target

NCT00437190 is a NA study that has completed, run by Medtronic Spinal and Biologics. The registered enrollment target is 494 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00437190, a NA study, has completed, sponsored by Medtronic Spinal and Biologics.

COMPLETED
Registry status
NA
Development phase
494 participants
Enrollment target

Study Summary

The purpose of this study is to establish the safety and effectiveness of the BRYAN(R) Cervical Disc Prosthesis in treating single-level degenerative disc disease of the cervical spine.

Interventions

  • DEVICE ATLANTIS™ Cervical Plate System and allograft
  • DEVICE BRYAN Cervical Disc Prosthesis

Trial Details

FieldValue
Enrollment Target 494 participants
Start Date 2003-06
Est. Completion 2016-05
Phase NA

Sponsor

Medtronic Spinal and Biologics

26 total trials

What the Registry Record Tells You About NCT00437190

The ClinicalTrials.gov registry entry for NCT00437190 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 494 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Spinal and Biologics, which has 26 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which ATLANTIS™ Cervical Plate System and allograft is the first listed.

NCT00437190 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00437190 about?

NCT00437190 is a clinical study titled "Pivotal IDE Study of the BRYAN(R) Cervical Disc Prosthesis in the Treatment of DDD Versus ACDF". The purpose of this study is to establish the safety and effectiveness of the BRYAN(R) Cervical Disc Prosthesis in treating single-level degenerative disc disease of the cervical spine.

What is the current status of trial NCT00437190?

This trial is currently completed. It is a NA study. The enrollment target is 494 participants. The study started on 2003-06. Estimated completion is 2016-05.

What interventions are being tested in trial NCT00437190?

The interventions under investigation include: ATLANTIS™ Cervical Plate System and allograft (DEVICE), BRYAN Cervical Disc Prosthesis (DEVICE).

Who is sponsoring clinical trial NCT00437190?

This trial is sponsored by Medtronic Spinal and Biologics, which has 26 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.